Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Catalyst Oncology Inc., DiagnoCure deal

CUR acquired Catalyst for $1 million in cash and

Read the full 97 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE